CDC Expanding Monkeypox Vaccine in Effort to Curb Spread as Disease Spreads to More Than 300 People in U.S.

With more than 300 confirmed cases of monkeypox in the United States, federal health officials are expanding efforts to vaccinate people against the disease, which has been confirmed in thousands of people in places around the world where it historically hasn't spread.

2022-06-29 18:44:06 - VI News Staff

The Centers for Disease Control and Prevention on Tuesday recommended vaccination against monkeypox for people presumed to be exposed, and not only those confirmed to have contracted the viral disease.

The CDC's new recommendation also covers men who have sex with men, and who recently had multiple sex partners in a place where monkeypox was known to be, or in an area where the virus is spreading.

"As the number of jurisdictions with cases increases, the need for medical countermeasures, including vaccines, continues to rise," said CDC Director Rochelle Walensky.

According to the Wall Street Journal, supplies of the preferred vaccine, called Jynneos, are currently limited, so health officials said they would distribute it through a four-tier distribution strategy that gives priority to places with the highest case rates. WSJ said New York City already launched a broader vaccination effort last week, though it was hampered by limited vaccine supplies amid high demand.

The U.S. Department of Health and Humans Services is expected to immediately allocate 56,000 doses of the two-dose Jynneos vaccine from the U.S. strategic national stockpile. The vaccine is made by Danish company Bavarian Nordic AS. Authorities are expecting another 240,000 doses to be made available in the coming weeks.

The V.I. Department said in May that there were no confirmed cases of monkeypox in the territory as of May 25. The department hasn't provided an update since, an indication that the disease hasn't been detected in the territory.

What is monkeypox?

According to WSJ, monkeypox is a viral disease that circulates mostly among rodents in parts of West and Central Africa. The disease was first discovered in 1958 when two outbreaks of a pox-like disease occurred in research monkeys, hence its name.

The first case in humans was recorded in 1970, in a 9-year-old boy in the Democratic Republic of Congo. Most cases since have been reported from rural, rainforest regions of the Congo Basin, although it has been detected in several countries in West and Central Africa. Nigeria, for example, typically reports a few dozen cases a year, WSJ said.

READ MORE: VI CONSORTIUM

More Posts